AstraZeneca buying drug developer Alexion for $39 billion

  • Home
  • AstraZeneca buying drug developer Alexion for $39 billion

AstraZeneca buying drug developer Alexion for $39 billion

Posted by The Analyst | December 12, 2020 | Politics

Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to … Click to Continue »

Read more here:: AstraZeneca buying drug developer Alexion for $39 billion

      

Related Blogs

No Image
Posted by The Analyst | February 24, 2021
Top board leaders resign after deadly Texas power outages
Top board leaders of Texas' embattled power grid operator said Tuesday they will resign following outrage over more than 4 million customers losing electricity last week during a deadly winter...
77 Likes
No Image
Posted by The Analyst | February 24, 2021
Asian shares slip on jitters over inflation, interest rates
Shares fell Wednesday in Asia as investors weighed the possibility that inflation might prompt central banks to adjust their ultra-low interest rate policies. Hong Kong led the decline, losing 2%...
91 Likes
No Image
Posted by The Analyst | February 24, 2021
For Senate rules arbiter, minimum wage is latest minefield
She's guided the Senate through two impeachment trials, vexed Democrats and Republicans alike with parliamentary opinions and helped rescue Electoral College certificates from a pro-Trump mob ransacking the Capitol. She...
68 Likes